35 Biggest Movers From Friday

Gainers

• ChemoCentryx, Inc. CCXI shares surged 96% to close at $38.41 on Friday. The FDA approved ChemoCentryx’s Tavneos (avacopan) as an adjunctive treatment for anti-neutrophil cytoplasmic autoantibody-associated vasculitis (ANCA-associated vasculitis or ANCA vasculitis).
• DatChat, Inc. DATS shares jumped 45.8% to close at $11.72 after gaining over 9% on Thursday.
• Voyager Therapeutics, Inc VYGR gained 44.5% to close at $5.55 on abnormally-high volume.
• Renren Inc. RENN gained 44.5% to settle at $23.98. Renren, last month, named Chris Palmer as its Chief Financial Officer.
• Huadi International Group Co., Ltd. HUDI surged 36.3% to close at $4.3199.
• ReShape Lifesciences Inc. RSLS shares gained 26.2% to close at $3.13. Maxim Group initiated coverage on Reshape Lifesciences with a Buy rating and announced a price target of $8.
• ORIC Pharmaceuticals, Inc. ORIC jumped 25.9% to settle at $15.46. ORIC Pharmaceuticals recently announced initial data from Phase 1b study evaluating ORIC-101 in combination with enzalutamide in patients with metastatic prostate cancer progressing on enzalutamide.
• MeaTech 3D Ltd. MITC surged 22% to close at $8.49. Meatech 3D recently said it is partnering with a collective led by Ashton Kutcher and Guy Oseary, together with strategic players like Effie Epstein, to accelerate growth in developing, commercializing cultured meat production technologies.
• Altisource Portfolio Solutions S.A. ASPS gained 21.2% to close at $14.24. The company recently agreed to sell Pointillist subsidiary for $150 million.
• Aehr Test Systems AEHR rose 16.7% to close at $14.24. Craig-Hallum raised the price target on Aehr Test Systems to $31 from $12, implying an 86.1% upside, and reiterated a Buy.
• Consensus Cloud Solutions, Inc. CCSI gained 15.7% to close at $64.88.
• Hallador Energy Company HNRG rose 14.7% to close at $4.29.
• Lilium N.V. LILM gained 13.7% to settle at $10.20.
• Lava Therapeutics B.V. LVTX surged 12.5% to close at $7.11.
• Macquarie Infrastructure Corporation MIC shares gained 12% to close at $3.71.
• Momentive Global Inc. MNTV gained 9.6% to close at $23.70. Momentive Global is weighing options, including a potential sale after receiving takeover interest, Bloomberg reported.
• Immuron Limited IMRN rose 7.1% to close at $3.77 as the company announced a recent publication of antiviral data from the IMM-124E preclinical and Phase 1/2a trials.
• Sundial Growers Inc. SNDL gained 5% to settle at $0.6804 after the company announced plans to acquire Alcanna for total consideration of approximately $346 million.

Losers

• Allogene Therapeutics, Inc. ALLO shares tumbled 46.1% to close at $13.13 after the company reported the FDA placed a hold on the company's AlloCAR T clinical trials.
• Agile Therapeutics, Inc. AGRX shares dropped 28.4% to settle at $0.6746 after the company announced an offering of common stock and warrants.
• Nkarta, Inc. NKTX fell 27.6% to settle at $18.10. Nkarta updated guidance on initial data readout of Phase 1 trial of NKX101 in relapsed or refractory acute myeloid leukemia or higher-risk myelodysplastic syndromes.
• Cellectis S.A. CLLS fell 24.2% to close at $9.11. Baird downgraded Cellectis from Outperform to Neutral and lowered the price target from $39 to $10.
• IsoPlexis Corporation ISO dropped 23.2% to close at $11.52 as the company priced its IPO at $15 per share.
• PagSeguro Digital Ltd. PAGS dipped 19% to settle at $36.57.
• Pyxis Oncology, Inc. PYXS dropped 17.5% to close at $13.20 after pricing IPO at $16 per share.
• Caribou Biosciences, Inc. CRBU fell 15.2% to close at $19.16.
• Century Therapeutics, Inc. IPSC dipped 14.7% to settle at $17.73. Century Therapeutics and Outpace Bio recently entered into research collaboration in CAR Engineering.
• Cidara Therapeutics, Inc. CDTX dipped 14.4% to settle at $1.60 after the company priced 14.8 million share offering at $1.55 per share.
• Blue Apron Holdings, Inc. APRN fell 13.3% to close at $6.84.
• LifeMD, Inc. LFMD dropped 12.1% to settle at $5.08.
• CareMax, Inc. CMAX fell 12% to close at $7.75.
• Kiromic BioPharma, Inc. KRBP fell 10.6% to close at $1.94. Kiromic BioPharma recently named Daniel Clark as interim Chief Financial Officer.
• Omeros Corporation OMER dropped 9.8% to close at $6.70. JP Morgan downgraded Omeros from Neutral to Underweight.
• Sharecare, Inc. SHCR fell 9.8% to close at $7.51.
• Lucira Health, Inc. LHDX fell 7.1% to close at $6.13. Lucira Health issued a statement on recall of FLOQSwabs by its Italian partner, Copan Italia.